Milestones achieved under research collaboration with LamKap Bio.
Antibodies being used as a T-cell targeting system to wipe out cancer cells.
CD47 is a potent “don’t eat me” signal that enables cancer cells to evade immune surveillance and killing by innate immune cells, such as macrophages.
The 3 companies enter Licensing Agreement for Antibody Drug Conjugate program.
Both companies joined their forces to develop Treatments for COVID- 19 Pneumonia and Other Disorders.
